Aflibercept ELISA
Enzyme immunoassay for the quantitative determination of free Aflibercept (Eylea®, Zaltrap®) in serum and plasma.
The solid phase (MTP) is coated by the target molecule, in this case VEGF.
Reference: IG-AA115
Barcode: 8682754930332
Legal Status: CE-Mark
Intended Use: This kit has been developed for the measurement of drug levels in research, diagnostic and biosimilar uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.
Assay Design:
Related Documents
Instructions for Use IG-AA115 705.20 KB
Material Safety Data Sheet (MSDS) IG-AA115 268.00 KB
Quality Control Certificates
Certificate of Analysis (CoA) Lot: AA115-120 144.86 KB
Certificate of Analysis (CoA) Lot: AA115-119 290.30 KB
Certificate of Analysis (CoA) Lot: AA115-118 286.84 KB
Quality Control Certificate Lot: AA115-117 144.49 KB
Quality Control Certificate Lot: AA115-116 296.46 KB
Quality Control Certificate Lot: AA115-115 302.66 KB
Quality Control Certificate Lot: AA115-114 159.11 KB
Quality Control Certificate Lot: AA115-113 159.72 KB
Quality Control Certificate Lot: AA115-112 159.66 KB
Quality Control Certificate Lot: AA115-111 298.20 KB
Quality Control Certificate Lot: AA115-110 159.77 KB
Quality Control Certificate Lot: AA115-109 159.63 KB
Quality Control Certificate Lot: AA115-108 159.52 KB
Quality Control Certificate Lot: AA115-107 159.60 KB
Quality Control Certificate Lot: AA115-106 159.63 KB
Quality Control Certificate Lot: AA115-105 159.72 KB
Quality Control Certificate Lot: AA115-104 159.75 KB
Quality Control Certificate Lot: AA115-103 160.05 KB
Quality Control Certificate Lot: AA115-102 160.56 KB
Eylea® is a trademark of Bayer.
Zaltrap® is a trademark of Sanofi Genzyme.
The Kit at a glance:
| Required Volume (µL) | 10 |
| Incubation Time (min) | 105 |
| Sample | Serum or Plasma |
| Package Size | 96 Tests |
| Standard Range (ng/mL, 10x) | 0-2000 |
| Detection Limit (ng/mL) | 5 |
| Spike Recovery (%) | >95 |
| Shelf Life (years) | 2 |
Standard Curve:
